1. Home
  2. MDAI vs XCUR Comparison

MDAI vs XCUR Comparison

Compare MDAI & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAI
  • XCUR
  • Stock Information
  • Founded
  • MDAI 2013
  • XCUR 2011
  • Country
  • MDAI United States
  • XCUR United States
  • Employees
  • MDAI N/A
  • XCUR N/A
  • Industry
  • MDAI Medical/Dental Instruments
  • XCUR Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDAI Health Care
  • XCUR Health Care
  • Exchange
  • MDAI Nasdaq
  • XCUR Nasdaq
  • Market Cap
  • MDAI 51.5M
  • XCUR 59.0M
  • IPO Year
  • MDAI N/A
  • XCUR N/A
  • Fundamental
  • Price
  • MDAI $2.48
  • XCUR $5.61
  • Analyst Decision
  • MDAI Strong Buy
  • XCUR
  • Analyst Count
  • MDAI 2
  • XCUR 0
  • Target Price
  • MDAI $4.75
  • XCUR N/A
  • AVG Volume (30 Days)
  • MDAI 503.5K
  • XCUR 213.9K
  • Earning Date
  • MDAI 08-11-2025
  • XCUR 06-27-2025
  • Dividend Yield
  • MDAI N/A
  • XCUR N/A
  • EPS Growth
  • MDAI N/A
  • XCUR N/A
  • EPS
  • MDAI N/A
  • XCUR N/A
  • Revenue
  • MDAI $29,962,000.00
  • XCUR N/A
  • Revenue This Year
  • MDAI N/A
  • XCUR N/A
  • Revenue Next Year
  • MDAI $15.14
  • XCUR N/A
  • P/E Ratio
  • MDAI N/A
  • XCUR N/A
  • Revenue Growth
  • MDAI 55.21
  • XCUR N/A
  • 52 Week Low
  • MDAI $0.82
  • XCUR $1.44
  • 52 Week High
  • MDAI $3.25
  • XCUR $36.00
  • Technical
  • Relative Strength Index (RSI)
  • MDAI 71.31
  • XCUR 20.83
  • Support Level
  • MDAI $2.07
  • XCUR $5.42
  • Resistance Level
  • MDAI $2.22
  • XCUR $8.28
  • Average True Range (ATR)
  • MDAI 0.17
  • XCUR 0.76
  • MACD
  • MDAI 0.01
  • XCUR -0.37
  • Stochastic Oscillator
  • MDAI 75.41
  • XCUR 2.32

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

About XCUR Exicure Inc.

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Share on Social Networks: